The aim of this study was to verify the predictive value of PNI for survival, treatment response rates, and treatment-related toxicity in SCLC patients of the China alpine region undergoing PD-L1/PD-1 inhibitor treatment. The gene discussed is CD274; the disease is small cell lung carcinoma.